Discovery st 16 pet ct scanner
The Discovery ST 16 PET/CT scanner is a medical imaging device that combines positron emission tomography (PET) and computed tomography (CT) technologies. It is designed to capture detailed images of the body's internal structures and functions.
Lab products found in correlation
9 protocols using discovery st 16 pet ct scanner
Lung CT Image Analysis for Nodule Detection
Amyloid-β PET Imaging Protocol
Standardized PET/CT Imaging Protocol
Brain PET/CT Imaging Protocol
PET Imaging of Amyloid Deposition
Ga-68 DOTA-NOC PET/CT Imaging Protocol
High-Resolution PET/CT Imaging of Soil Columns
Dual-Time Point FDG PET/CT Imaging Protocol
ST16 PET/CT scanner (GE Healthcare). Patients fasted for at least 4 h before imaging. Dual time-point scans were performed 1 and 2 h after intravenous administration of 3–3.7 MBq/kg FDG. Low-dose non-enhanced CT images (3–4 mm slices) were acquired for attenuation correction and localization of lesions identified on PET images. Immediately after CT examination, the identical axial field of view (154 mm) was scanned using PET for 2–3 min per table position depending on the patient's condition and scanner performance. The acquired data were reconstructed as 128 × 128 matrix images (pixel size, 4.7 × 3.25 mm) using Fourier rebinning and ordered subset expectation maximization algorithms. PET and CT examinations were performed with the patient performing normal tidal breathing in the supine position. Regions of interest were set to include the entire intramammary abnormal uptake on attenuation-corrected FDG PET images. The primary breast tumor and the SUVmax was quantified using a Xeleris workstation (GE Healthcare). Semi-quantitative SUVmax parameters from the first and second scans were defined as SUVmax1 and SUVmax2, respectively. The RI was calculated using the following equation:
PET/CT Imaging of Primary Lung Tumors
FDG positivity in each primary lung tumor was retrospectively evaluated. The SUVmax was determined by drawing a region of interest (ROI) around the tumor and within the affected lymph node and using the maximum SUV recorded within each ROI. The SUV was calculated as the activity per millimeter within a ROI divided by the dose injected in MBq/g bodyweight.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!